Cancer has long been one of the most formidable challenges in medicine, affecting millions of lives worldwide. However, the landscape of cancer treatment is undergoing a profound transformation, with targeted therapy emerging as a beacon of hope for patients and clinicians alike. As we stand on the cusp of a new era in oncology, it’s crucial to understand the concept of targeted therapy and its potential to revolutionise cancer treatment in the coming decade.

Understanding Targeted Therapy

Targeted therapy represents a paradigm shift in cancer treatment. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapy is designed to interfere with specific molecular targets that are associated with cancer[1]. These targets are typically proteins that control how cancer cells grow, divide, and spread throughout the body.

To appreciate the significance of this approach, it’s essential to understand that cancer is not a single disease, but rather a complex group of diseases characterised by uncontrolled cell growth. Each cancer type—and indeed, each individual tumor—may have unique genetic and molecular features that drive its growth and survival. Targeted therapies are developed to exploit these specific features, offering a more personalised approach to treatment.

The Mechanism of Action

Targeted therapies work in various ways, but all aim to disrupt the processes that cancer cells rely on to survive and proliferate. Some common mechanisms include:

1. Blocking growth signals: Many targeted drugs interfere with proteins that signal cancer cells to grow and divide[2].
2. Cutting off blood supply: Some therapies target the formation of new blood vessels that feed tumors, a process known as angiogenesis[2].
3. Delivering cell-killing substances: Certain targeted therapies act as vehicles to deliver toxic substances directly to cancer cells[2].
4. Triggering the immune system: Some targeted therapies help the body’s immune system recognise and destroy cancer cells more effectively[2].

To illustrate this, let’s consider the example of trastuzumab (Herceptin), a monoclonal antibody used in the treatment of HER2-positive breast cancer. HER2 is a protein that promotes cell growth and is found in excessive amounts in about 20% of breast cancers. Trastuzumab binds to HER2 receptors on cancer cells, blocking growth signals and flagging these cells for destruction by the immune system[1].

The Current Landscape

As of 2025, targeted therapies have already made significant inroads in cancer treatment. The U.S. Food and Drug Administration (FDA) has approved numerous targeted therapies for various cancer types, including lung, colorectal, breast, and prostate cancers[3]. These treatments have shown remarkable efficacy in specific patient populations, often with fewer side effects compared to traditional chemotherapy.

For instance, in lung cancer, drugs targeting mutations in the EGFR gene or ALK gene rearrangements have dramatically improved outcomes for patients with these specific genetic alterations. The FLAURA trial demonstrated that osimertinib, an EGFR inhibitor, improved progression-free survival in patients with EGFR-mutated non-small cell lung cancer to 18.9 months, compared to 10.2 months with older EGFR inhibitors[4].

The Promise of the Next Decade

As we look towards the future, several trends suggest that targeted therapy will play an increasingly central role in cancer treatment:

1. Expansion of biomarker-driven therapies: Advances in genomic sequencing and molecular diagnostics are enabling the identification of more targetable mutations across various cancer types. This will likely lead to the development of new targeted therapies and the expansion of existing ones to new indications[5].
2. Combination approaches: Researchers are exploring combinations of targeted therapies to overcome resistance mechanisms and improve efficacy. For example, combining BRAF and MEK inhibitors has shown superior results in melanoma treatment compared to single-agent therapy[6].
3. Antibody-drug conjugates (ADCs): These “smart bombs” combine the targeting precision of monoclonal antibodies with potent cytotoxic agents. The field of ADCs is rapidly evolving, with over 100 ADCs in clinical trials as of 2025[7].
4. Precision medicine: The integration of genomic profiling, artificial intelligence, and targeted therapies is paving the way for truly personalised cancer treatment. This approach aims to match patients with the most effective targeted therapies based on their tumour’s molecular profile[8].
5. Liquid biopsies: The development of blood-based tests to detect circulating tumour DNA (ctDNA) is expected to revolutionise how we monitor treatment response and detect early signs of resistance to targeted therapies[9].

Challenges and Considerations

While the potential of targeted therapy is immense, it’s important to acknowledge the challenges that lie ahead:

1. Resistance: Cancer cells can develop resistance to targeted therapies over time, necessitating ongoing research into resistance mechanisms and strategies to overcome them[10].
2. Toxicity: Although generally better tolerated than chemotherapy, targeted therapies can still cause significant side effects, some of which may be unique to these agents[11].
3. Cost: Many targeted therapies are expensive, raising concerns about accessibility and healthcare costs[12].
4. Patient selection: Identifying the right patients for each targeted therapy remains crucial. Not all patients with a particular cancer type will benefit from a specific targeted therapy[13].

The Impact on Clinical Practice

For medical professionals, the rise of targeted therapies necessitates a shift in approach to cancer diagnosis and treatment. Molecular testing is becoming an integral part of cancer diagnosis, guiding treatment decisions and patient management. Clinicians must stay abreast of rapidly evolving treatment landscapes and interpret complex genomic data to make informed decisions.

Moreover, the management of side effects associated with targeted therapies requires specific knowledge and expertise. While these side effects are often different from those seen with traditional chemotherapy, they can be significant and require prompt recognition and management[14].

Conclusion

The advent of targeted therapy marks a new chapter in the fight against cancer. By harnessing our growing understanding of cancer biology, these treatments offer the promise of more effective, less toxic therapies tailored to individual patients. As we enter this new decade, the continued development and refinement of targeted therapies, coupled with advances in diagnostics and precision medicine, hold the potential to dramatically improve outcomes for cancer patients.

However, realising this potential will require ongoing research, collaboration across disciplines, and a commitment to addressing the challenges of resistance, toxicity, and accessibility. As medical professionals, our role is to embrace these advances, continually educate ourselves, and work towards integrating these promising therapies into our practice to provide the best possible care for our patients.

The journey ahead is both exciting and challenging, but it offers hope for a future where cancer treatment is more precise, effective, and tailored to each individual patient.

References:

[1] Targeted therapy is a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread[12].

[2] Targeted therapies can block or turn off chemical signals that tell the cancer cell to grow and divide, change proteins within the cancer cells so the cells die, stop making new blood vessels to feed the cancer cells, trigger the immune system to kill the cancer cells, or carry toxins to the cancer cells to kill them, but not normal cells[28].

[3] The U.S. Food and Drug Administration (FDA) has approved numerous targeted therapies for various cancer types, including lung, colorectal, breast, and prostate cancers[34].

[4] The FLAURA trial demonstrated that osimertinib, an EGFR inhibitor, improved progression-free survival in patients with EGFR-mutated non-small cell lung cancer to 18.9 months, compared to 10.2 months with older EGFR inhibitors[34].

[5] Advances in genomic sequencing and molecular diagnostics are enabling the identification of more targetable mutations across various cancer types[36].

[6] Combining BRAF and MEK inhibitors has shown superior results in melanoma treatment compared to single-agent therapy[34].

[7] As of 2025, there are over 100 new ADCs in clinical trials[27].

[8] The integration of genomic profiling, artificial intelligence, and targeted therapies is paving the way for truly personalised cancer treatment[4].

[9] The development of blood-based tests to detect circulating tumour DNA (ctDNA) is expected to revolutionise how we monitor treatment response and detect early signs of resistance to targeted therapies[4].

[10] Cancer cells can develop resistance to targeted therapies over time, necessitating ongoing research into resistance mechanisms and strategies to overcome them[23].

[11] Although generally better tolerated than chemotherapy, targeted therapies can still cause significant side effects, some of which may be unique to these agents[12].

[12] Many targeted therapies are expensive, raising concerns about accessibility and healthcare costs[36].

[13] Not all patients with a particular cancer type will benefit from a specific targeted therapy[26].

[14] The management of side effects associated with targeted therapies requires specific knowledge and expertise[1].

Sources
[1] Targeted cancer therapies: Clinical pearls for primary care – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC9842142/
[2] How Targeted Therapies Are Used to Treat Cancer https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy/what-is.html
[3] Potential Successes and Challenges of Targeted Cancer Therapies https://academic.oup.com/jncimono/article/2019/53/lgz008/5551349?login=false
[4] Experts Forecast Cancer Research and Treatment Advances in 2025 https://www.aacr.org/blog/2025/01/10/experts-forecast-cancer-research-and-treatment-advances-in-2025/
[5] Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA … https://pubmed.ncbi.nlm.nih.gov/37686423/
[6] Impact of Targeted Therapy on the Survival of Patients With … https://pmc.ncbi.nlm.nih.gov/articles/PMC8777330/
[7] Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA … https://pmc.ncbi.nlm.nih.gov/articles/PMC10487969/
[8] An overview of targeted cancer therapy – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC4662664/
[9] What is Targeted Therapy? | Cancer Treatment https://www.cancercouncil.com.au/cancer-information/cancer-treatment/targeted-therapy/what-is-targeted-therapy/
[10] Targeted Therapy for Cancer | OHSU https://www.ohsu.edu/knight-cancer-institute/targeted-therapy-cancer
[11] The year in cancer: Advances made in 2024, predictions for 2025 https://www.foxnews.com/health/year-cancer-advances-made-2024-predictions-2025
[12] Targeted Therapy for Cancer – NCI https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
[13] Types of Cancer Treatments: Targeted Therapy & Precision Oncology https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/targeted-therapy
[14] Targeted Therapy: Types, Benefits & What to Expect | Mercy https://www.mercy.net/service/targeted-therapy/
[15] Targeted Cancer Therapies – AAFP https://www.aafp.org/pubs/afp/issues/2021/0201/p155.html
[16] What are targeted cancer drugs? – Cancer Research UK https://www.cancerresearchuk.org/about-cancer/treatment/targeted-cancer-drugs/what-are-targeted-cancer-drugs
[17] Targeted Therapy for Cancer – NCI https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_article/public/cgov_image/media_image/100/000/2/files/precision-medicine-infographic-piece-article.png?h=fbeb4613&itok=Wk8vy2QJ&sa=X&ved=2ahUKEwiDu7DhjPGKAxV9HNAFHcAMAEUQ_B16BAgOEAI
[18] Targeted Therapy for Cancer – NCI https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
[19] Targeted Therapy for Cancer – NCI https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_article/public/cgov_image/media_image/100/000/2/files/precision-medicine-infographic-piece-article.png?h=fbeb4613&itok=Wk8vy2QJ&sa=X&ved=2ahUKEwit2bDhjPGKAxVw6ckDHcr2FMUQ_B16BAgJEAI
[20] Targeted Therapy: What It Is, Process & Side Effects https://my.clevelandclinic.org/health/treatments/22733-targeted-therapy
[21] Targeted Therapy Overview – Facing Our Risk of Cancer Empowered https://www.facingourrisk.org/info/risk-management-and-treatment/cancer-treatment/by-treatment-type/targeted-therapy/overview
[22] Targeted Drug Therapy | American Cancer Society https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy.html
[23] Potential Successes and Challenges of Targeted Cancer Therapies https://academic.oup.com/jncimono/article/2019/53/lgz008/5551349?login=false
[24] Advancements in Targeted Therapies Revolutionize Ovarian Cancer … https://www.targetedonc.com/view/advancements-in-targeted-therapies-revolutionize-ovarian-cancer-treatment
[25] Exploring treatment options in cancer: tumor treatment strategies https://www.nature.com/articles/s41392-024-01856-7
[26] Targeted therapy – Cancer Council Victoria https://www.cancervic.org.au/cancer-information/treatments/treatments-types/targeted-therapy
[27] The exciting future of targeted therapies – BBC https://www.bbc.com/storyworks/rewriting-cancer/the-exciting-future-of-targeted-therapies
[28] How Targeted Therapies Are Used to Treat Cancer https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy/what-is.html
[29] AACR Annual Meeting 2023: The Past, Present, and Future of … https://www.aacr.org/blog/2023/04/28/annual-meeting-2023-the-past-present-and-future-of-targeted-therapies-for-pediatric-cancer/
[30] Molecular targeted therapy for anticancer treatment – Nature https://www.nature.com/articles/s12276-022-00864-3
[31] Small molecules in targeted cancer therapy: advances, challenges … https://www.nature.com/articles/s41392-021-00572-w
[32] Targeted therapies for cancer – UF Health https://ufhealth.org/care-sheets/targeted-therapies-for-cancer
[33] Targeted Therapy – Abramson Cancer Center | Penn Medicine https://www.pennmedicine.org/cancer/navigating-cancer-care/treatment-types/immunotherapy/targeted-therapy
[34] Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA … https://pmc.ncbi.nlm.nih.gov/articles/PMC10487969/
[35] Advances in Cancer Treatment Can Mean Longer and Better Lives … https://www.medstarhealth.org/blog/cancer-treatment-advances
[36] Six Game-Changing Cancer Treatments Built for Unstoppable … https://www.geneonline.com/six-game-changing-cancer-treatments-built-for-unstoppable-growth-in-2025-part-ii/
[37] References | Successes and Limitations of Targeted Cancer Therapy https://karger.com/books/book/193/chapter-abstract/6019789/References?redirectedFrom=fulltext
[38] Targeted cancer therapies – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC4012258/